Table 1. Disease characteristics and medical treatments.
| Control | Age | Sex | ||||||
|---|---|---|---|---|---|---|---|---|
| 02C | 69 | F | ||||||
| 04C | 69 | F | ||||||
| 05C | 64 | F | ||||||
| 07C | 65 | M | ||||||
| 09C | 47 | F | ||||||
| 10C | 53 | F | ||||||
| 11C | 45 | F | ||||||
| 12C | 65 | M | ||||||
| 14C | 65 | M | ||||||
| Psoriasis patients |
Ao | Psa | Medication | Topical treatment | PASI | Type and severity | ||
| 02P | 62 | F | 17 | 0 | 0 | 0 | 9.0 | small plaque, moderate |
| 03P | 64 | M | 9 | 0 | adalimumab | mometasone | 13.3 | plaque, severe |
| 05P | 65 | F | 6 | 0 | 0 | betametasone/salisylic acid, calcipotriene | 10.0 | plaque, guttate, moderate |
| 06P | 20 | M | 15 | 1 | 0 | calcipotriene/betamethasone | 14.7 | plaque, moderate |
| 08P | 50 | M | 25 | 1 | methotrexate | 0 | 14.8 | plaque, guttate, severe |
| 09P | 60 | M | 30 | 0 | 0 | calcipotriene/betamethasone | 11.9 | plaque, moderate |
Abbreviations: 0, No; 1, Yes; F, female; M, male; Psa, Psoriasis arthritis; PASI, Psoriasis Area Severity Index; Ao, Age of onset.